Paper37192552
Salidroside protects mice from high-fat diet-induced obesity by modulating the gut microbiota.
Liu J and 6 others. Int Immunopharmacol, 2023. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. Salidroside protects mice from high-fat diet-induced obesity by modulating the gut microbiota. Papers, record 37192552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37192552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Salidroside protects mice from high-fat diet-induced obesity by modulating the gut microbiota.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diet, High-Fat | Major topic |
| Gastrointestinal Microbiome | Major topic |
| Animals | |
| Mice | |
| Mice, Obese | |
| RNA, Ribosomal, 16S | |
| Obesity | |
| Inflammation | |
| Mice, Inbred C57BL | |
| Glucosides | |
| Phenols |
Source PubMed
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42338004 | Preparation, characterization and evaluation of polysaccharides from Rosa roxburghii Tratt. fruit on ameliorating senior osteoporosis in rats induced by d-galactose and low calcium diet. | J Sci Food Agric | 2026 | https://conductscience.org/library/papers/42338004 | PubMed |
| 40978035 | Salidroside suppresses gastric cancer progression via miR-1343-3p-mediated repression of ACOT11 and disruption of fatty acid metabolism. | Front Oncol | 2025 | https://conductscience.org/library/papers/40978035 | PubMed |
| 40972715 | Gut microbiota: A key player for soluble dietary fiber in regulating inflammatory disease. | J Adv Res | 2026 | https://conductscience.org/library/papers/40972715 | PubMed |
| 40699724 | Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry and Network Pharmacology Reveal the Mechanisms of Rhodiola crenulata in Improving Non-Alcoholic Fatty Liver Disease. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/40699724 | PubMed |
| 40331200 | Gut microbiota-mitochondrial crosstalk in obesity: novel mechanistic insights and therapeutic strategies with traditional Chinese medicine. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40331200 | PubMed |
| 40001495 | Natural Compounds Regulate Macrophage Polarization and Alleviate Inflammation Against ALI/ARDS. | Biomolecules | 2025 | https://conductscience.org/library/papers/40001495 | PubMed |
| 39677297 | Erhong Jiangzhi Decoction Inhibits Lipid Accumulation and Alleviates Nonalcoholic Fatty Liver Disease with Nrf2 Restoration Under Obesity. | J Inflamm Res | 2024 | https://conductscience.org/library/papers/39677297 | PubMed |
| 39027133 | Repairing gut barrier by traditional Chinese medicine: roles of gut microbiota. | Front Cell Infect Microbiol | 2024 | https://conductscience.org/library/papers/39027133 | PubMed |
| 38841616 | Rhodiola rosea: a review in the context of PPPM approach. | EPMA J | 2024 | https://conductscience.org/library/papers/38841616 | PubMed |
| 38155743 | Co-Housing and Fecal Microbiota Transplantation: Technical Support for TCM Herbal Treatment of Extra-Intestinal Diseases Based on Gut Microbial Ecosystem Remodeling. | Drug Des Devel Ther | 2023 | https://conductscience.org/library/papers/38155743 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37192552
GET https://conductscience.org/api/papers/v1/37192552/authors